Skip Navigation
Menu
Case Reports |1 February 1950

MASSIVE RESPONSE TO A MERCURIAL DIURETIC IN A CASE OF CONGESTIVE HEART FAILURE*

PHILIP H. ROSS, M.D.; SIDNEY GRAU, M.D.

Article, Author, and Disclosure Information
Author, Article, and Disclosure Information
×
FULL TEXT

This content is PDF only. Please click on the PDF icon to access.

Abstract

The value of mercurial diuretics in the treatment of congestive heart failure is well known. Instances of remarkable response to this medication have been occasionally reported. We recently observed such a case, in which massive diuresis followed the use of mercuhydrin. In our patient the use of this drug produced a greater diuretic response than any heretofore reported in the American literature.

CASE REPORT

A 46 year old Negress was admitted to Michael Reese Hospital on August 5, 1947, with symptoms and signs of right heart failure, manifested chiefly by massive anasarca and moderate ascites. Her present illness dated from

FULL TEXT
PDF
Not Available
Citations
Citation

ROSS PH, GRAU S. MASSIVE RESPONSE TO A MERCURIAL DIURETIC IN A CASE OF CONGESTIVE HEART FAILURE*. Ann Intern Med. 1950;32:335–338. doi: https://doi.org/10.7326/0003-4819-32-2-335

Download citation file:

© 2019

×
Permissions

Published: Ann Intern Med. 1950;32(2):335-338.

DOI: 10.7326/0003-4819-32-2-335

1 Citations

Related Articles
Review: Metformin is linked to reduced mortality in type 2 diabetes with comorbid CKD and CHF
Annals of Internal Medicine; 166 (8): JC46
Clinical Outcomes of Metformin Use in Populations With Chronic Kidney Disease, Congestive Heart Failure, or Chronic Liver Disease: A Systematic Review
Annals of Internal Medicine; 166 (3): 191-200
Annals for Educators - 7 February 2017
Annals of Internal Medicine; 166 (3): ED3
Routine Echocardiography Screening for Asymptomatic Left Ventricular Dysfunction in Childhood Cancer Survivors: A Model-Based Estimation of the Clinical and Economic Effects
Annals of Internal Medicine; 160 (10): 661-671
View MoreView Less

Journal Club
Review: Metformin is linked to reduced mortality in type 2 diabetes with comorbid CKD and CHF
Annals of Internal Medicine; 166 (8): JC46
Review: Cardiac resynchronization reduces mortality and hospitalizations in patients with either more or less symptomatic HF
Annals of Internal Medicine; 155 (4): JC2-7
In hemodialysis patients with CHF, adding telmisartan to standard ACE inhibitors reduced CHD mortality and admissions
Annals of Internal Medicine; 154 (10): JC5-5
NT-proBNP–guided and clinically guided treatment reduced short-term but not long-term mortality in chronic HF
Annals of Internal Medicine; 152 (8): JC4-4
View MoreView Less

Related Topics
Cardiology
Heart Failure

Cardiology, Heart Failure.

PubMed Articles
A Population-Based Analysis of Intraoperative Cardiac Arrest in the United States.
Anesth Analg 2019.
View More

Results provided by: PubMed

CONTINUE WITH LIMITED ACCESS
Annals of Internal Medicine
To receive access to the full text of freely available articles, alerts, and more. You will be directed to acponline.org to complete your registration.
×
acp link acp
silverchair link silverchair

Copyright © 2019 American College of Physicians. All Rights Reserved.

Print ISSN: 0003-4819 | Online ISSN: 1539-3704

Privacy Policy

|

Conditions of Use

This site uses cookies. By continuing to use our website, you are agreeing to our privacy policy. | Accept
×

You need a subscription to this content to use this feature.

×
PDF Downloads Require Access to the Full Article.
Annals of Internal Medicine
To receive access to the full text of freely available articles, alerts, and more. You will be directed to acponline.org to complete your registration.
×
Access to this Free Content Requires Users to be Registered and Logged In. Please Choose One of the Following Options
Annals of Internal Medicine
To receive access to the full text of freely available articles, alerts, and more. You will be directed to acponline.org to complete your registration.
×